Cas:64623-50-3 2-bromobut-3-en-1-ol manufacturer & supplier

Chemical Name:2-bromobut-3-en-1-ol

CAS.NO:64623-50-3

Synonyms:2-Brom-but-3-en-1-ol;3-Buten-1-ol,2-bromo;2-bromo-but-3-en-1-ol;2-Brom-3-buten-1-ol;2-BROMO-3-BUTEN-1-OL

Molecular Formula:C₄H₇BrO

Molecular Weight:151.00200

HS Code:2905590090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:20.23000

Exact Mass:149.96800

LogP:0.92820

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Brom-but-3-en-1-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-BROMO-3-BUTEN-1-OL physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Brom-but-3-en-1-ol Use and application,3-Buten-1-ol,2-bromo technical grade,usp/ep/jp grade.

Related News: Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development. 2-bromobut-3-en-1-ol manufacturer After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply. 2-bromobut-3-en-1-ol supplier Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body. 2-bromobut-3-en-1-ol vendor Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development. 2-bromobut-3-en-1-ol factory At the same time, due to the relatively late development of the bulk drug business in China, most of the established bulk drug companies are currently in the field of commonly used generic drug bulk drugs. Stand up.